J.P. Morgan Initiates Coverage on Warner Chilcott (WCRX) with a Neutral
More News related to WCRX
- Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2008 and Updates 2008 Full Year Guidance
- Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2008 Financial Results
- J.P. Morgan Initiates Coverage on Warner Chilcott (WCRX) with a Neutral
- Roth Capital Downgrades Warner Chilcott (WCRX) to Hold
- Warner Chilcott (WCRX) Tops Q2 View; Guides FY08
More News related to New Coverage
- Raymond James Starts Millicom (MICC) at Strong Buy
- Stifel Nicolaus Starts City National (CYN) at Hold
- Stifel Nicolaus Starts eHealth (Nasdaq: HLTH) with a Buy
- Wasserman & Associates initiates coverage on American Physicians Service Group (AMPH) with a Buy
- Jesup & Lamont Initiates Coverage on AutoZone (AZO) with a Hold.
J.P. Morgan initiates coverage on Warner Chilcott (Nasdaq: WCRX) with a Neutral.
Warner Chilcott Limited (Warner Chilcott) is a specialty pharmaceutical company focused on segments of the United States pharmaceutical market, women’s healthcare and dermatology.
Related Categories
New CoverageStocks Mentioned
-0.03Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
